(Q41586598)

4 October 2017

1 reference

title

Rhabdomyosarcoma. Biology and treatment (English)

1 reference

4 October 2017

1 reference

Pappo AS

1

1 reference

PubMed ID

9286294

4 October 2017

Shapiro DN

series ordinal

2

1 reference

PubMed ID

9286294

4 October 2017

Crist WM

series ordinal

3

1 reference

4 October 2017

1 August 1997

1 reference

Pediatric Clinics of North America

4 October 2017

1 reference

4 October 2017

44

1 reference

4 October 2017

4

1 reference

4 October 2017

953-972

1 reference

Spindle cell rhabdomyosarcoma. A prognostically favorable variant of rhabdomyosarcoma

4 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

The Third Intergroup Rhabdomyosarcoma Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Common solid tumors of childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

N-myc gene is amplified in alveolar rhabdomyosarcomas (RMS) but not in embryonal RMS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

The value of adjuvant chemotherapy in the management of sarcomas in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Hyperfractionated radiation in children with rhabdomyosarcoma--results of an Intergroup Rhabdomyosarcoma Pilot Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

The improvement in survival associated with combined chemotherapy in childhood rhabdomyosarcoma. A historical comparison of 345 patients in the same center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Primary chemotherapy in the treatment of rhabdomyosarcoma in children: trial of the International Society of Pediatric Oncology (SIOP) preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Late effects of therapy in orbital rhabdomyosarcoma in children. A report from the Intergroup Rhabdomyosarcoma Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Rhabdomyosarcoma: a clinicopathological study and classification of 39 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Differential expression of myogenic regulatory genes, MyoD1 and myogenin, in human rhabdomyosarcoma sublines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Childhood rhabdomyosarcoma: experience of the Children's Solid Tumour Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features. A report of the Intergroup Rhabdomyosarcoma Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

The Intergroup Rhabdomyosarcoma Study-I. A final report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

The Intergroup Rhabdomyosarcoma Study-II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

DNA ploidy and proliferative activity (S-phase) in childhood soft-tissue sarcomas: their value as prognostic indicators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Tumor-cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma. The Intergroup Rhabdomyosarcoma Study Committee of the Children's Cancer Group and the Pediatric Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Relaxation of imprinted genes in human cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate. A report from the Intergroup Rhabdomyosarcoma Study Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites. A report from the Intergroup Rhabdomyosarcoma Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: a report from the International Rhabdomyosarcoma Workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Prognostic factors in 281 children with nonmetastatic rhabdomyosarcoma (RMS) at diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Molecular differential pathology of rhabdomyosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

MyoD and the regulation of myogenesis by helix-loop-helix proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Incidence of meningeal involvement by rhabdomyosarcoma of the head and neck in children: a report of the Intergroup Rhabdomyosarcoma Study (IRS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

Comparison of the rates of response to ifosfamide and cyclophosphamide in primary unresectable rhabdomyosarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970539-3

10.1016/S0031-3955(05)70539-3

7 January 2021

Identifiers

DOI

1 reference

4 October 2017

1 reference

PubMed ID

9286294